Previous studies have demonstrated that aberrant expression of RacGAP1 occurs in different cancer types, including cervical cancer [14], esophageal cancer [15], glioma [16], ovarian cancer [17], colorectal cancer [18], gastric cancer [19] and hepatocellular carcinoma [13]. Here, RACGAP1 is linked to central nervous system cancer.